Basel Medical Group Stock Market Value
| BMGL Stock | 0.80 0.02 2.56% |
| Symbol | Basel |
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. If investors know Basel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Basel Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Basel Medical Group is measured differently than its book value, which is the value of Basel that is recorded on the company's balance sheet. Investors also form their own opinion of Basel Medical's value that differs from its market value or its book value, called intrinsic value, which is Basel Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Basel Medical's market value can be influenced by many factors that don't directly affect Basel Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Basel Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Basel Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Basel Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Basel Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Basel Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Basel Medical.
| 10/27/2025 |
| 01/25/2026 |
If you would invest 0.00 in Basel Medical on October 27, 2025 and sell it all today you would earn a total of 0.00 from holding Basel Medical Group or generate 0.0% return on investment in Basel Medical over 90 days. Basel Medical is related to or competes with P3 Health, Vicarious Surgical, Longduoduo Company, Precipio, IBio Common, Nutriband, and Iterum Therapeutics. More
Basel Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Basel Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Basel Medical Group upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 42.69 | |||
| Value At Risk | (11.63) | |||
| Potential Upside | 12.31 |
Basel Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Basel Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Basel Medical's standard deviation. In reality, there are many statistical measures that can use Basel Medical historical prices to predict the future Basel Medical's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.97) | |||
| Total Risk Alpha | (1.51) | |||
| Treynor Ratio | (0.43) |
Basel Medical January 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.42) | |||
| Mean Deviation | 4.91 | |||
| Coefficient Of Variation | (869.87) | |||
| Standard Deviation | 7.19 | |||
| Variance | 51.72 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.97) | |||
| Total Risk Alpha | (1.51) | |||
| Treynor Ratio | (0.43) | |||
| Maximum Drawdown | 42.69 | |||
| Value At Risk | (11.63) | |||
| Potential Upside | 12.31 | |||
| Skewness | 1.33 | |||
| Kurtosis | 4.91 |
Basel Medical Group Backtested Returns
Basel Medical Group secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11 % return per unit of risk over the last 3 months. Basel Medical Group exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Basel Medical's Mean Deviation of 4.91, risk adjusted performance of (0.08), and Standard Deviation of 7.19 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.96, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Basel Medical will likely underperform. At this point, Basel Medical Group has a negative expected return of -0.83%. Please make sure to confirm Basel Medical's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Basel Medical Group performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.01 |
Very weak reverse predictability
Basel Medical Group has very weak reverse predictability. Overlapping area represents the amount of predictability between Basel Medical time series from 27th of October 2025 to 11th of December 2025 and 11th of December 2025 to 25th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Basel Medical Group price movement. The serial correlation of -0.01 indicates that just 1.0% of current Basel Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.01 | |
| Spearman Rank Test | -0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Basel Medical Correlation, Basel Medical Volatility and Basel Medical Alpha and Beta module to complement your research on Basel Medical. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Basel Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.